Skip to main navigation Skip to search Skip to main content

Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

Translated title of the contribution: Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
  • F. Morschhauser
  • , J. Radford
  • , A. van Hoof
  • , U. Vitolo
  • , P. Soubeyran
  • , H. Tilly
  • , P.C. Huijgens
  • , A. Kolstad
  • , F. D'Amore
  • , M. Gonsalez Diaz
  • , M. Petrini
  • , C. Sebban
  • , P.L. Zinzani
  • , M.H.J. van Oers
  • , W. van Putten
  • , A. Bischof-Delaloye
  • , A. Rohatiner
  • , G. Salles
  • , J. Kuhlmann
  • , A. Hagenbeek

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPhase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Original languageUndefined/Unknown
Pages (from-to)5156-5164
Number of pages9
JournalJournal of Clinical Oncology
Volume26
Issue number32
Publication statusPublished - 2008

Cite this